3-Bromopyruvate: targets and outcomes

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• 3-bromopyruvate (3-BP) is a pyruvate mimetic investigated for anticancer properties.
• It is recognized for its potential to inhibit glycolysis and affect tumor cell metabolism.

Purpose of the Study:

• To review the molecular targets of 3-BP.
• To elucidate the mechanisms underlying its efficacy and tumor specificity.
• To explore its potential as an anticancer therapeutic.

Main Methods:

• Literature review of reported molecular targets and mechanisms of 3-BP.
• Analysis of in vivo studies on tumor growth inhibition and eradication.
• Evaluation of 3-BP's cytotoxic effects and potential off-target actions.

Main Results:

• 3-BP exhibits efficacy through a combination of glycolytic and mitochondrial targets.
• Its effects extend to the tumor microenvironment, enhancing in vivo activity.
• Cytotoxicity is primarily attributed to alkylation of key thiols, not solely pyruvate mimicry.

Conclusions:

• The wide range of molecular targets contributes to 3-BP's efficacy and tumor specificity.
• Further research is needed to understand 3-BP's pharmacokinetics and toxicity in normal cells.
• 3-BP represents a promising agent for cancer therapy, warranting continued investigation.